Immunization guidelines for adults are routinely updated, and primary care clinicians should be aware of the most current immunization recommendations. Within the past 2 years, 2 new vaccines were approved by the US Food and Drug Administration (FDA) for adults. These include Shingrix, a herpes zoster vaccine containing a specific protein subunit of the virus (recombinant glycoprotein E) with a novel adjuvant (an added substance that enhances or prolongs the immunologic response), and Heplisav-B, a single-antigen recombinant hepatitis B vaccine with a novel adjuvant. The eTable in the Supplement details the Advisory Committee on Immunization Practices (ACIP) 2019 immunization schedule for adults by age group.1
Sha BE. Adult Immunization Update. JAMA. Published online August 19, 2019322(11):1096–1097. doi:10.1001/jama.2019.12739
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: